SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-24-130855
Filing Date
2024-12-20
Accepted
2024-12-20 16:37:33
Documents
15
Period of Report
2024-12-20
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2431725d2_8k.htm   iXBRL 8-K 26374
2 EXHIBIT 99.1 tm2431725d2_ex99-1.htm EX-99.1 27225
6 GRAPHIC tm2431725d2_ex99-1img001.jpg GRAPHIC 2026
  Complete submission text file 0001104659-24-130855.txt   239049

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA fencf-20241220.xsd EX-101.SCH 3015
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE fencf-20241220_lab.xml EX-101.LAB 34240
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE fencf-20241220_pre.xml EX-101.PRE 22358
17 EXTRACTED XBRL INSTANCE DOCUMENT tm2431725d2_8k_htm.xml XML 3695
Mailing Address PO BOX 13628 68 TW ALEXANDER DRIVE RESEARCH TRIANGLE PARK NC 27709
Business Address PO BOX 13628 68 TW ALEXANDER DRIVE RESEARCH TRIANGLE PARK NC 27709 (919) 636-4530
FENNEC PHARMACEUTICALS INC. (Filer) CIK: 0001211583 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-32295 | Film No.: 241568494
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)